Doxorubicin, vinblastine and gemcitabine (AVG), a novel regimen excluding bleomycin for the treatment of early stage Hodgkin Lymphoma (HL): Results of CALGB 50203
- Citation:
- Blood vol 110 (11) abstr 214
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 130
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- D. J. Straus A. S. Lacasce M. E. Juweid L. Kostakoglu N. C. Hall J. L. Johnson S. Jung G. P. Canellos L. Schwartz B. D. Cheson
- Networks:
- Study
- CALGB-50203
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: